<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="editorial" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1085346</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2022.1085346</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: The polysaccharides from marine organisms and fungi: Biological functions and molecular mechanisms</article-title>
<alt-title alt-title-type="left-running-head">Pereira et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2022.1085346">10.3389/fphar.2022.1085346</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Pereira</surname>
<given-names>Leonel</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/159097/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chang</surname>
<given-names>Chia-Chuan</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1702826/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ding</surname>
<given-names>Jianxun</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/489389/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lin</surname>
<given-names>Tung-Yi</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1413595/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Zhong</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/300117/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>ARNET Associate Laboratory</institution>, <institution>Department of Life Sciences</institution>, <institution>MARE&#x2014;Marine and Environmental Sciences Centre</institution>, <institution>University of Coimbra</institution>, <addr-line>Coimbra</addr-line>, <country>Portugal</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Pharmacy</institution>, <institution>School of Pharmacy</institution>, <institution>National Taiwan University Taipei</institution>, <addr-line>Taipei</addr-line>, <country>Taiwan</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Changchun Institute of Applied Chemistry</institution>, <institution>Chinese Academy of Sciences (CAS)</institution>, <addr-line>Changchun</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>School of Medicine</institution>, <institution>National Yang Ming Chiao Tung University Taipei</institution>, <addr-line>Taipei</addr-line>, <country>Taiwan</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>College of Life Science and Technology</institution>, <institution>Jinan University Guangzhou</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited and reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/25157/overview">Heike Wulff</ext-link>, University of California, Davis, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Leonel Pereira, <email>leonel.pereira@uc.pt</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>11</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>1085346</elocation-id>
<history>
<date date-type="received">
<day>31</day>
<month>10</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>11</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Pereira, Chang, Ding, Lin and Liu.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Pereira, Chang, Ding, Lin and Liu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" journal-id="Front. Pharmacol." xlink:href="https://www.frontiersin.org/researchtopic/35005" ext-link-type="uri">Editorial on the Research Topic <article-title>The polysaccharides from marine organisms and fungi: Biological functions and molecular mechanisms</article-title>
</related-article>
<kwd-group>
<kwd>polyporus polysaccharide</kwd>
<kwd>iron oxide nanoparticles</kwd>
<kwd>medicinal mushrooms</kwd>
<kwd>porphyran</kwd>
<kwd>antimicrobial peptides</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>In recent years, there has been an increase in studies on applications of marine algae (macro- and micro-), fungi and other marine organisms, as a result of the identification of different substances synthesized by these organisms. The immense biodiversity and consequent variability in the biochemical composition of the biomass obtained from algae cultures, combined with their genetic improvement and the development of large-scale cultivation technology, have made them a target of interest for the industry, namely the food industry, and pharmaceutical.</p>
<p>Algae and fungi are a potential source of obtaining various biologically active ingredients, such as carotenoids, fatty acids, vitamins, polysaccharides, among others, with an efficiency superior to that verified by traditional terrestrial vegetable cultures, these can be used in the development of functional foods, which has led to the recent increase in commercial interest in marine algae and fungi.</p>
<p>The natural properties of algae allow the extraction of compost with active antimicrobial, antitumoral, antiviral, etc., compounds that are difficult to synthesize, thus allowing greater efficiency in drug development. For In addition, there are currently several cosmetics on the market, aimed at skin care and sun protection, which contain marine algae or fungi extracts in their composition.</p>
<p>In this Research Topic, four original research articles and one review article were published, the latter entitled &#x201c;Fungal Mushrooms: A Natural Compound with Therapeutic Applications,&#x201d; (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2022.925387/full">Chugh et al.</ext-link>) in which approximately 130 medicinal activities such as antitumor, immunomodulation, antioxidant, radical scavenging, cardioprotective and antiviral actions are assumed to be produced by the various varieties of medicinal mushrooms.</p>
<p>Of the original research articles, one was published with the title &#x201c;Polyporus Polysaccharide Ameliorates Bleomycin-Induced Pulmonary Fibrosis by Suppressing Myofibroblast Differentiation <italic>via</italic> TGF-&#x3b2;/Smad2/3 Pathway&#x201d; (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2020.00767/full">Jiang et al.</ext-link>) and, in this work, it was demonstrated that the polysaccharide Polyporus (PPS) markedly improves bleomycin-induced pulmonary fibrosis in mice.</p>
<p>The authors of the article &#x201c;Hyaluronic Acid&#x2013;Stabilized Fe<sub>3</sub>O<sub>4</sub> Nanoparticles for Promoting <italic>In Vivo</italic> Magnetic Resonance Imaging of Tumors,&#x201d; (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2022.918819/full">Zhang et al.</ext-link>) reported the creation of hyaluronic acid (HA)-stabilized Fe<sub>3</sub>O<sub>4</sub> nanoparticles prepared by a hydrothermal coprecipitation method and followed by electrostatic adsorption of HA onto the nanoparticle surface, demonstrating that nanoparticles can be used as effective contrast agents for magnetic resonance imaging (MRI) both <italic>in vitro</italic> in HeLa cells and <italic>in vivo</italic> in a rodents xenografted HeLa tumor model.</p>
<p>The article titled &#x201c;Porphyran from <italic>Porphyra haitanensis</italic> Alleviates Obesity by Reducing Lipid Accumulation and Modulating gut Microbiota Homeostasis&#x201d; (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2022.942143/full">Wang et al.</ext-link>). In this article it is mentioned that the polysaccharide porphyran possesses various activities, while the effects of the porphyran from <italic>Neoporphyra haitanensis</italic> (formerly <italic>Porphyra haitanensis</italic>) (Rhodophyta) on obesity are rarely reported. In summary, this study illustrated that porphyran extracted from <italic>N. haitanensis</italic> has the potential to be developed as an anti-obesity agent.</p>
<p>Last but not least, the article entitled &#x201c;Recombinant Phage Displaying ToAP2D Peptide with Antifungal Activity against <italic>Sporothrix globosa</italic>&#x201d; (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2022.1022651/full">Yan et al.</ext-link>) addresses the antifungal effect on <italic>Sporothrix</italic> and the corresponding mechanism. The authors of this study believe that the recombinant phage inhibits the growth of <italic>Sporothrix</italic> by adjusting the immune response of the mice, inducing <italic>Sporothrix</italic> apoptosis and improving the animal&#x2019;s survival. Therefore, this study offers a new approach for the preparation of antimicrobial peptides.</p>
</body>
<back>
<sec id="s1">
<title>Author contributions</title>
<p>All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.</p>
</sec>
<sec sec-type="COI-statement" id="s2">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s3">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</back>
</article>